Pharmacological effects of an aldehyde type / -adrenoceptor blocking agent with vasodilating properties

Author： Chiu C.-C.   Lin Y.-T.   Tsai C.-H.   Liang J.-C.   Chiang L.-C.   Wu J.-R.   Chen I.-J.   Yeh J.-L.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.34, Iss.6, 2000-06, pp. : 391-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vasodilating -adrenoceptor blockers as cardiovascular therapeutics

By Toda N.  

Pharmacology and Therapeutics, Vol. 100, Iss. 3, 2003-12 ,pp. : 215-234

Elsevier

Access to resources Recommend Favorite

Antianginal Effects of YM430, a Novel Calcium Entry-Blocking and -Adrenoceptor-Blocking Agent in Several Experimental Angina Models - a double-blind placebo-controlled crossover trial

By Shibasaki K.   Arai Y.   Uchida W.   Okazaki T.   Asano M.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 4, 1997-10 ,pp. : 545-550

Elsevier

Access to resources Recommend Favorite

5-HT 3 Receptor Blocking Properties of the Antiparkinsonian Agent, Talipexole

By Nishio H.   Kohno Y.   Fujii A.   Negishi Y.   Inoue A.   Nakata Y.  

General Pharmacology, Vol. 27, Iss. 5, 1996-07 ,pp. : 779-785

Elsevier

Access to resources Recommend Favorite

Synthesis and Pharmacological Effects of the Anti-Cancer Agent 2-Methoxyestradiol

By  

Current Pharmaceutical Design, Vol. 21, Iss. 38, 2015-11 ,pp. : 5453-5466

Bentham Science Publishers

Access to resources Recommend Favorite

The [(methyloxy)imino]methyl moiety (MOIMM) in the design of a new type of -adrenergic blocking agent

By Balsamo A.   Macchia M.   Martinelli A.   Rossello A.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 4, 1999-04 ,pp. : 283-291

Elsevier

Access to resources Recommend Favorite